Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to evaluate the safety and tolerability of long-term administration of Lacosamide at doses up to 400 mg/day in Japanese and Chinese adults with Epilepsy who have completed...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
UCB Pharma SA
Collaborators
NCT02531880 · Epilepsy
NCT06097195 · Epilepsy
NCT06315322 · Childhood Absence Epilepsy, Juvenile Absence Epilepsy
NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more
NCT06794606 · Epilepsy
86026
Beijing
86027
Beijing
86015
Changchun
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions